8-18057200-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The ENST00000314146.10(ASAH1):​c.*334G>A variant causes a splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0224 in 303,576 control chromosomes in the GnomAD database, including 108 homozygotes. In-silico tool predicts a benign outcome for this variant. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.025 ( 56 hom., cov: 32)
Exomes 𝑓: 0.020 ( 52 hom. )

Consequence

ASAH1
ENST00000314146.10 splice_region

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -0.121
Variant links:
Genes affected
ASAH1 (HGNC:735): (N-acylsphingosine amidohydrolase 1) This gene encodes a member of the acid ceramidase family of proteins. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed. Processing of this preproprotein generates alpha and beta subunits that heterodimerize to form the mature lysosomal enzyme, which catalyzes the degradation of ceramide into sphingosine and free fatty acid. This enzyme is overexpressed in multiple human cancers and may play a role in cancer progression. Mutations in this gene are associated with the lysosomal storage disorder, Farber lipogranulomatosis, and a neuromuscular disorder, spinal muscular atrophy with progressive myoclonic epilepsy. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 8-18057200-C-T is Benign according to our data. Variant chr8-18057200-C-T is described in ClinVar as [Benign]. Clinvar id is 362364.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0253 (3853/152266) while in subpopulation AFR AF = 0.047 (1953/41544). AF 95% confidence interval is 0.0453. There are 56 homozygotes in GnomAd4. There are 1927 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 56 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ASAH1NM_177924.5 linkc.*334G>A 3_prime_UTR_variant Exon 14 of 14 ENST00000637790.2 NP_808592.2 Q13510-1Q53H01A8K0B6

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ASAH1ENST00000637790.2 linkc.*334G>A 3_prime_UTR_variant Exon 14 of 14 1 NM_177924.5 ENSP00000490272.1 Q13510-1

Frequencies

GnomAD3 genomes
AF:
0.0253
AC:
3852
AN:
152148
Hom.:
56
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0471
Gnomad AMI
AF:
0.00219
Gnomad AMR
AF:
0.0145
Gnomad ASJ
AF:
0.0565
Gnomad EAS
AF:
0.00250
Gnomad SAS
AF:
0.0354
Gnomad FIN
AF:
0.0325
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.0132
Gnomad OTH
AF:
0.0234
GnomAD4 exome
AF:
0.0195
AC:
2958
AN:
151310
Hom.:
52
Cov.:
0
AF XY:
0.0208
AC XY:
1703
AN XY:
81916
show subpopulations
African (AFR)
AF:
0.0502
AC:
235
AN:
4678
American (AMR)
AF:
0.0116
AC:
84
AN:
7230
Ashkenazi Jewish (ASJ)
AF:
0.0570
AC:
205
AN:
3594
East Asian (EAS)
AF:
0.00387
AC:
28
AN:
7226
South Asian (SAS)
AF:
0.0344
AC:
986
AN:
28666
European-Finnish (FIN)
AF:
0.0253
AC:
179
AN:
7072
Middle Eastern (MID)
AF:
0.0308
AC:
17
AN:
552
European-Non Finnish (NFE)
AF:
0.0127
AC:
1073
AN:
84652
Other (OTH)
AF:
0.0198
AC:
151
AN:
7640
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.514
Heterozygous variant carriers
0
132
265
397
530
662
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0253
AC:
3853
AN:
152266
Hom.:
56
Cov.:
32
AF XY:
0.0259
AC XY:
1927
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.0470
AC:
1953
AN:
41544
American (AMR)
AF:
0.0144
AC:
221
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0565
AC:
196
AN:
3468
East Asian (EAS)
AF:
0.00251
AC:
13
AN:
5180
South Asian (SAS)
AF:
0.0354
AC:
171
AN:
4826
European-Finnish (FIN)
AF:
0.0325
AC:
345
AN:
10602
Middle Eastern (MID)
AF:
0.0136
AC:
4
AN:
294
European-Non Finnish (NFE)
AF:
0.0132
AC:
899
AN:
68030
Other (OTH)
AF:
0.0232
AC:
49
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
196
392
589
785
981
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
44
88
132
176
220
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00837
Hom.:
3
Bravo
AF:
0.0243

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Farber lipogranulomatosis Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
4.9
DANN
Benign
0.62
PhyloP100
-0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs115127411; hg19: chr8-17914709; API